Last reviewed · How we verify
NCT06614556
Quantifying the Trainability of Peripheral Nerve Function in Young and Older Adults.
NA trial testing Resistance Training in Nerve Degeneration in 59 participants. Completed in 18 July 2023.
18 July 2023
Quick facts
| Lead sponsor | Oklahoma State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 59 |
| Start date | 20 September 2022 |
| Primary completion | 18 July 2023 |
| Estimated completion | 18 July 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Resistance Training
Conditions studied
- Nerve Degeneration — all drugs for Nerve Degeneration →
- Healthy Aging — all drugs for Healthy Aging →
Sponsor
Oklahoma State University
Who can join
Adults 18 to 100, any sex, with Nerve Degeneration or Healthy Aging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this project is to identify the effects of hand grip resistance training on nerve speed of the hand muscles and to quantify whether age plays a role in those effects. Two groups (young and older adults) underwent a 4-week resistance training intervention with nerve conduction velocity measured before and after. There were also two control groups (young and older adults) who performed the testing 4 weeks apart, but did not engage in the intervention.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
An Exercise Intervention May Counteract the Degradation of Nerve Conduction from Age-Related Disuse.
Shields JE, Smith CM, Reese SM, Dos Santos ML, et al · · 2025 · PMID 40440515 · DOI 10.1249/mss.0000000000003767
Verify or expand the search:
- PubMed search for NCT06614556
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Resistance Training
Trials testing the same drug.
- NCT07135232 — The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. · NA · recruiting
- NCT07278440 — An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregi · NA · not yet recruiting
- NCT07364149 — Acute Effects of Structured Exercise and Static Stretching on Vascular Function, Neuromuscular Performance, and Metaboli · NA · recruiting
- NCT07262931 — Effect Of Sensory Motor Training Versus Resistance Training Among Individuals With Knee Osteoarthritis. · NA · not yet recruiting
- NCT07045727 — Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Olde · NA · recruiting
Other recruiting trials for Nerve Degeneration
Currently open trials in the same condition.
- NCT05091112 — Nerve Composition of Human Lumbar Dorsal Primary Rami and Its Medial Branch · recruiting
Other Oklahoma State University trials
Trials by the same sponsor.
- NCT06970457 — The Interaction of Body Composition, Sex Hormones and Exercise in Men · NA · recruiting
- NCT06840431 — Randomized Control Trial of the Co-Parenting for Resilience Program · NA · enrolling by invitation
- NCT05977192 — Mobile Health-based Motivational Interviewing to Promote COVID-19 Vaccination · NA · completed
- NCT06518863 — Ultra-Processed Foods and Executive Function · NA · completed
- NCT06310603 — Determinants and Outcomes of High vs. Low Ultra-processed Feeding · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06614556 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oklahoma State University
- Last refreshed: 26 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06614556.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing